357 related articles for article (PubMed ID: 11565031)
1. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
Moll J; Barzaghi P; Lin S; Bezakova G; Lochmüller H; Engvall E; Müller U; Ruegg MA
Nature; 2001 Sep; 413(6853):302-7. PubMed ID: 11565031
[TBL] [Abstract][Full Text] [Related]
2. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA
J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.
Bentzinger CF; Barzaghi P; Lin S; Ruegg MA
FASEB J; 2005 Jun; 19(8):934-42. PubMed ID: 15923403
[TBL] [Abstract][Full Text] [Related]
4. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
[TBL] [Abstract][Full Text] [Related]
5. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation.
Matsumura K; Yamada H; Saito F; Sunada Y; Shimizu T
Histol Histopathol; 1997 Jan; 12(1):195-203. PubMed ID: 9046055
[TBL] [Abstract][Full Text] [Related]
6. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
7. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
[TBL] [Abstract][Full Text] [Related]
8. Adeno-Associated Virus-Mediated Mini-Agrin Delivery Is Unable to Rescue Disease Phenotype in a Mouse Model of Limb Girdle Muscular Dystrophy Type 2I.
Vannoy CH; Zhou H; Qiao C; Xiao X; Bang AG; Lu QL
Am J Pathol; 2017 Feb; 187(2):431-440. PubMed ID: 28107841
[TBL] [Abstract][Full Text] [Related]
9. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.
Langenbach KJ; Rando TA
Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
12. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
[TBL] [Abstract][Full Text] [Related]
13. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
[TBL] [Abstract][Full Text] [Related]
14. Animal models of muscular dystrophies.
Nonaka I
Lab Anim Sci; 1998 Feb; 48(1):8-17. PubMed ID: 9517883
[TBL] [Abstract][Full Text] [Related]
15. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice.
Saito F; Masaki T; Saito Y; Nakamura A; Takeda S; Shimizu T; Toda T; Matsumura K
J Neurochem; 2007 Jun; 101(6):1712-22. PubMed ID: 17326765
[TBL] [Abstract][Full Text] [Related]
16. Synaptic plasticity in the dy2J mouse model of laminin alpha2-deficient congenital muscular dystrophy.
Anderson JL; Head SI; Morley JW
Brain Res; 2005 Apr; 1042(1):23-8. PubMed ID: 15823249
[TBL] [Abstract][Full Text] [Related]
17. Linker proteins restore basement membrane and correct
Reinhard JR; Lin S; McKee KK; Meinen S; Crosson SC; Sury M; Hobbs S; Maier G; Yurchenco PD; Rüegg MA
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659438
[No Abstract] [Full Text] [Related]
18. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
Martin PT
Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
20. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.
Shibuya S; Wakayama Y; Inoue M; Kojima H; Oniki H
Med Electron Microsc; 2003 Dec; 36(4):213-20. PubMed ID: 16228654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
